PINZANI, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 9.513
EU - Europa 5.363
AS - Asia 701
AF - Africa 26
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
SA - Sud America 3
Totale 15.614
Nazione #
US - Stati Uniti d'America 9.487
PL - Polonia 1.738
SE - Svezia 875
IE - Irlanda 797
UA - Ucraina 612
IT - Italia 448
HK - Hong Kong 398
DE - Germania 393
FI - Finlandia 209
GB - Regno Unito 143
CN - Cina 124
JO - Giordania 70
TR - Turchia 53
FR - Francia 40
CH - Svizzera 38
BE - Belgio 34
VN - Vietnam 28
CA - Canada 25
SC - Seychelles 23
RU - Federazione Russa 18
IN - India 15
NL - Olanda 11
SG - Singapore 11
ES - Italia 6
EU - Europa 4
NZ - Nuova Zelanda 4
EG - Egitto 3
BR - Brasile 2
CL - Cile 1
EE - Estonia 1
IR - Iran 1
JP - Giappone 1
MX - Messico 1
Totale 15.614
Città #
Warsaw 1.738
Fairfield 1.486
Chandler 998
Jacksonville 980
Dublin 796
Woodbridge 662
Ashburn 630
Cambridge 597
Seattle 583
Houston 503
Wilmington 499
Ann Arbor 328
Princeton 216
Hong Kong 213
Boardman 174
Boston 158
Lawrence 113
Altamura 111
Medford 100
Buffalo 94
San Diego 69
Beijing 64
Florence 46
Norwalk 43
Izmir 41
Milan 41
Bern 36
Frankfurt Am Main 35
Brussels 34
Auburn Hills 29
Andover 26
Los Angeles 26
Shanghai 26
Hillsboro 24
New York 24
West Jordan 22
Dong Ket 18
Verona 17
Bremen 15
Dearborn 14
Toronto 13
London 12
Singapore 11
Phoenix 10
Falls Church 9
Laurel 9
Ottawa 9
Bagno a Ripoli 7
Rome 6
Guangzhou 5
Moscow 5
Salerno 5
Barcelona 4
Hefei 4
Las Vegas 4
Nanjing 4
Pune 4
Redmond 4
Redwood City 4
San Mateo 4
Tappahannock 4
Detroit 3
Düsseldorf 3
Fuzhou 3
Manchester 3
Montalbano Jonico 3
Saint Petersburg 3
Washington 3
Arnsberg 2
Auckland 2
Brescia 2
Cairo 2
Central 2
Chicago 2
Chiswick 2
Empoli 2
Kolkata 2
Kunming 2
Lappeenranta 2
Leawood 2
Marechal Candido Rondon 2
Modica 2
Naaldwijk 2
New Delhi 2
Salamanca 2
Trumbull 2
Anaheim 1
Anghiari 1
Ardabil 1
Arezzo 1
Atlanta 1
Bergamo 1
Bolzano 1
Caldogno 1
Chaoyang 1
Christchurch 1
Comeana 1
Cuauhtémoc 1
Dallas 1
Faenza 1
Totale 11.837
Nome #
Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis 238
Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells 235
Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells. 221
Evaluation of intracellular signalling pathways in response to insulin-like growth factor I in apoptotic-resistant activated human hepatic stellate cells. 218
Intermittent fever in a patient with apparent fatty liver 217
Inhibition by pentoxifylline of extracellular signal-regulated kinase activation by platelet-derived growth factor in hepatic stellate cells 214
Intrabiliary metastasis from rectal cancer mimicking peripheral papillary-type cholangiocarcinoma. 212
Welcome to Fibrogenesis & Tissue Repair 208
Differential expression of two isoforms of the chemokine receptor CXCR3 determines the ultimate effect of IP-10 on survival of human hepatic stellate cells (HSC) 208
The mitogenic effect of platelet-derived growth factor in human hepatic stellate cells requires calcium influx 207
Fat-storing cells as liver-specific pericytes: spatial dynamic of agonist-stimulated intracellular calcium transients. 191
Hepatic wound repair. 176
Calcium-dependent activation of NF-kappa B by the adipokine resistin in hepatic stellate cells 169
Mammalian target of rapamycin mediates the angiogenic effects of leptin in human hepatic stellate cells. 133
Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells. 117
Acute viral hepatitis increases liver stiffness values measured by transient elastography 116
Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites. 113
Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C 113
Non-invasive assessment of liver fibrosis in patients with HBV-related chronic liver disease undergoing antiviral treatment: A preliminary study 111
Liver stiffness correlates with methotrexate cumulative dose in patients with rheumatoid arthritis. 107
The orphan nuclear receptor COUP-TFII coordinates hypoxia-independent proangiogenic responses in hepatic stellate cells 104
Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. 103
MARCKS is a downstream effector in platelet-derived growth factor-induced cell motility in activated human hepatic stellate cells 102
Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: role of nitric oxide. 101
Differential requirement of members of the MAPK family for CCL2 expression by hepatic stellate cells 100
4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells. 100
Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C 99
gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis. 99
Expression and function of integrin receptors for collagen and laminin in cultured human hepatic stellate cells. 98
Endothelin-1 inhibits secretin-stimulated ductal secretion by interacting with ETA receptors on large cholangiocytes. 97
Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells 96
Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclo-oxygenase metabolites in hepatic stellate cells 96
Activation of p38(MAPK) mediates the angiostatic effect of the chemokine receptor CXCR3-B. 95
THE ACTIN CYTOSKELETON AS A NOVEL TARGET OF AMP-ACTIVATED PROTEIN KINASE (AMPK) IN HEPATIC STELLATE CELLS 95
Expression of platelet-derived growth factor in newly formed cholangiocytes during experimental biliary fibrosis in rats. 95
CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells 94
Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. 93
ADMA correlates with portal pressure in patients with compensated cirrhosis. 92
Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice 92
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. 92
Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C. 92
Mitotic Checkpoint CHK2 Upregulation is Linked to Chromosomal Instability in Human Hepatocellular Carcinoma 92
NGF and Trk-A as a novel autocrine loop in the early stages of hepatic stellate cell (HSC) activation 91
Regulation of platelet-derived growth factor secretion and gene expression in human liver fat-storing cells. 91
Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis. 91
Fibrosis in chronic liver diseases: diagnosis and management 89
Expression of the thrombin receptor in human liver: up-regulation during acute and chronic injury. 88
Induction of procollagen type I gene expression and synthesis in human hepatic stellate cells by 4-hydroxy-2,3-nonenal and other 4-hydroxy-2,3-alkenals is related to their molecular structure. 87
Performance of Doppler ultrasound in the prediction of severe portal hypertension in hepatitis C virus-related chronic liver disease 87
EFFECTS OF NITRIC OXIDE (NO)-DONORS ON ACTIVATED HUMAN HEPATIC STELLATE CELLS (HSC): CELLULAR BASIS FOR THE TREATMENT OF PORTAL HYPERTENSION. 87
Alcoholic and non-alcoholic fatty liver in adolescents: a worrisome convergence. 85
Cross-talk between phosphatidylinositol 3-kinase (PI3-K) and the NA+/H+ exchanger in hepatic stellate cells (HSC): effect of canrenone. 85
Altered furosemide pharmacokinetics in chronic alcoholic liver disease with ascites contributes to diuretic resistance 85
Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans. 84
Elastography for the non-invasive assessment of liver disease: limitations and future developments 84
Transient elastography for the assessment of liver fibrosis in patients with chronic viral hepatitis: The missing tool? 84
Farnesoid X Receptor Critically Determines the Fibrotic Response in Mice but Is Expressed to a Low Extent in Human Hepatic Stellate Cells and Periductal Myofibroblasts. 84
Effects of low-dose captopril on renal hemodynamics and function in patients with cirrhosis of the liver. 84
Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. 83
Actions of platelet-derived growth factor isoforms in mesangial cells. 82
Immediate effects of furosemide on renal hemodynamics in chronic liver disease with ascites. 82
Systemic hemodynamics and renal function in cirrhotic patients during plasma volume expansion. 82
Progression of fibrosis in chronic liver diseases: time to tally the score. 82
Contraction of human hepatic stellate cells activated in culture: a role for voltage-operated calcium channels. 82
Serum markers detect the presence of liver fibrosis: a cohort study. 81
Albumin and stellate cell activation: wonders will never cease! 81
Progression of fibrosis in chronic liver diseases: time to tally the score 80
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial 80
Biosynthesis of platelet-activating factor and its 1O-acyl analogue by liver fat-storing cells. 79
Thromboxane-receptor blockade increases water diuresis in cirrhotic patients with ascites. 79
Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis 79
Transient elastography (TE) is more effective for the identification of HCV patients with advanced (F3-F4) rather than significant (F2-F4) liver fibrosis 79
Modulation of hepatic fibrogenesis by antioxidants. 78
Focal adhesion kinase and phospholipase C gamma involvement in adhesion and migration of human hepatic stellate cells. 78
Integrin-mediated stimulation of monocyte chemotactic protein-1 expression. 77
Cultured human liver fat-storing cells produce monocyte chemotactic protein-1. Regulation by proinflammatory cytokines. 77
COMPARISON BETWEEN HEPATIC VENOUS PRESSURE GRADIENT (HVPG) AND LIVER STIFFNESS MEASUREMENT (LSM) IN PATIENTS WITH HCV-RELATED FIBROSIS/CIRRHOSIS 77
Dose-dependent and divergent effects of superoxide anion on cell death, proliferation and migration of activated human hepatic stellate cells 76
The biphasic nature of hypoxia-induced directional migration of activated human hepatic stellate cells. 76
The Ras antagonist, farnesylthiosalicylic acid (FTS), inhibits experimentally-induced liver cirrhosis in rats 76
Expression of platelet-derived growth factor in a model of acute liver injury. 75
Undulin RNA and protein expression in normal and fibrotic human liver. 75
Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans 75
Involvement of phosphatidylinositol 3-kinase in the activation of extracellular signal-regulated kinase by PDGF in hepatic stellate cells. 75
Signal transduction in hepatic stellate cells. 74
Angiogenesis in liver disease. 74
Transient elastography (TE) is more effective for the identification of HCV patients with severe (> F3) rather than significant (> F2) liver fibrosis 74
The cellular and molecular basis of liver fibrogenesis. 73
Fibrogenesi epatica: valutazione dell'espressione genica di citochine fibrogeniche e dei tipi più rappresentanti di collagene. 73
Fibrosis and cirrhosis reversibility: clinical features and implications 73
Increased risk of hepatocellular carcinoma and liver cirrhosis in vinyl chloride workers: synergistic effect of occupational exposure with alcohol intake 73
Diagnostic power of fibroscan in predicting liver fibrosis in nonalcoholic fatty liver disease. 73
Effects of repeated atrial natriuretic peptide bolus injections in cirrhotic patients with refractory ascites. 73
Multiple biological effects of endothelin-1 in fat-storing cells isolated from human liver. 72
Altered renal and platelet arachidonic acid metabolism in cirrhosis. 72
Expression of transmembrane 4 superfamily (TM4SF) proteins and their role in hepatic stellate cell motility and wound healing migration. 71
Expression of somatostatin receptors in normal and cirrhotic human liver and in hepatocellular carcinoma 70
Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario 70
Novel insights into the biology and physiology of the Ito cell. 70
Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma. 70
Totale 10.238
Categoria #
all - tutte 38.371
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.371


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.169 0 0 0 0 0 0 0 0 0 0 634 535
2019/20203.703 295 350 82 372 358 487 371 511 327 173 310 67
2020/20212.453 195 142 241 256 86 349 61 256 168 330 128 241
2021/20221.356 62 134 52 60 58 64 51 75 86 51 304 359
2022/20233.661 375 460 153 346 351 687 453 232 441 21 84 58
2023/2024972 63 151 229 58 46 111 25 249 7 33 0 0
Totale 15.679